Jiangxi Fushine Pharmaceutical Plans to Increase VC Product Capacity to 10,000 Tons/Year Through Technical Upgrades, Expected Completion by Q2 2026

Deep News
2025/11/16

Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) disclosed in its investor relations activity report that, according to Wind data, the price of VC products has remained around RMB 50,000 per ton over the past two years. Recently, VC prices have surged rapidly, driven by strong demand growth in energy storage batteries, power batteries, as well as macroeconomic policies and industry supply-demand dynamics.

Currently, the company has an annual production capacity of 8,000 tons for VC products and approximately 4,000 tons for FEC products. It plans to expand VC production capacity to 10,000 tons per year through technical upgrades, with the project expected to be completed by the second quarter of 2026. Depending on market demand and industry capacity expansion, the company may further increase VC and FEC production capacities to 20,000 tons and 5,000 tons per year, respectively.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10